Cardiol Therapeutics Inc logo

Cardiol Therapeutics Inc - Class A

NEW
STU:CT9 (Canada)   Class A
€ 1.214 +0.032 (+2.71%) Aug 7
At Loss
P/B:
9.21
Market Cap:
€ 142.04M ($ 164.21M)
Enterprise V:
€ 124.97M ($ 144.49M)
Volume:
5.00K
Avg Vol (2M):
3.81K
Trade In:
Volume:
5.00K
At Loss

Cardiol Therapeutics Inc (STU:CT9) Dividend

Cardiol Therapeutics Inc (STU:CT9) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -16.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:CT9 Dividend

Does Cardiol Therapeutics Inc (STU:CT9) pay a dividend?

Cardiol Therapeutics Inc (STU:CT9) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Cardiol Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Cardiol Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -16.1% over the past 3 years.

What are dividend-paying alternatives to Cardiol Therapeutics Inc?

For dividend-paying alternatives in Cardiol Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.